Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

Biopharma innovation: Will there be sufficient incentives in the future?

  • Biopharma
Ezekiel Emanuel wrote an op-ed in the New York Times last month, which…

Read more